Back

Early rhythm control in patients with atrial fibrillation and cancer: a subgroup analysis of the EAST-AFNET 4 trial

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation management: rhythm control, outcomes, and specific populations Rhythm Control, Antiarrhythmic Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Djemail Ismaili

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Dynamic changes in anaemia and phenotype-specific risk of adverse outcomes in patients with atrial fibrillation treated with NOACs
Doctor A. Rigutini (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
The RIBAT-AFRICA-AF Registry (Registry Initiative Across Borders for Atrial Fibrillation in Africa)
Professor A. Moustaghfir (Casablanca, MA)
Abstract Slides Video
Presentation thumbnail
Comparative clinical effectiveness and safety of amiodarone versus dronedarone in patients with atrial fibrillation
Miss L. Liu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
The placebo effect in atrial fibrillation ablation: insights from a post hoc analysis of the PFA-SHAM trial
Doctor M. Hozman (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation and early-onset cognitive decline: a multicenter 14-year cross-sectional analysis of 1,641 patients in North Macedonia
Doctor V. Zhaku (Tetovo, MK)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation management: rhythm control, outcomes, and specific populations

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Different risk of atrial fibrillation according to the type of cancer: a nationwide population-based study
28 August 2020
thumbnail
Congress Presentation
Rate or rhythm control in cancer and atrial fibrillation
26 August 2023
thumbnail
Congress Presentation
Left atrial appendage closure after severe bleeding in anticoagulated patients with atrial fibrillation and cancer: real world data from PERSEO registry
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources